US FDA announces new program to boost domestic drug manufacturing

The US Food and Drug Administration on Thursday announced a new program to strengthen the domestic pharmaceutical supply chain, by facilitating construction of manufacturing sites in the United States. 

The program, called FDA PreCheck, aims to streamline review of domestic pharmaceutical manufacturing and eliminate unnecessary regulatory requirements, the FDA said. 

The program also introduces a two-phase approach to facilitate new US drug manufacturing facilities.